Europe Human Liver Models Market to Grow at a CAGR of 12.1% to reach US$ 1,87,244.81 thousand from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Human Liver Models Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Human Liver Models Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Rising demand for drug testing and development.
5.1.3 Increased focus on reducing animal testing.
5.1.4 Growing prevalence of liver diseases.

5.2 Market Opportunities

5.2.1
5.2.2 Development of more accurate liver models.
5.2.3 Expansion into personalized medicine applications.
5.2.4 Collaborations with pharmaceutical companies for research.

5.3 Future Trends

5.3.1
5.3.2 Increased use of 3D bioprinting technologies.
5.3.3 Focus on multi-organ models for research.
5.3.4 Growth in demand for organ-on-a-chip systems.

5.4 Impact of Drivers and Restraints

6. Europe Human Liver Models Market Regional Analysis

6.1 Europe Human Liver Models Market Overview

6.2 Europe Human Liver Models Market Revenue 2019-2028 (US$ Thousand)

6.3 Europe Human Liver Models Market Forecast Analysis

7. Europe Human Liver Models Market Analysis – by Type

7.1 Liver Organoids

7.1.1 Overview
7.1.2 Liver Organoids: Europe Human Liver Models Market – Revenue and Forecast to 2031 (US$ Thousand)

7.2 Liver-on-a-chip

7.2.1 Overview
7.2.2 Liver-on-a-chip: Europe Human Liver Models Market – Revenue and Forecast to 2031 (US$ Thousand)

7.3 2D Models

7.3.1 Overview
7.3.2 2D Models: Europe Human Liver Models Market – Revenue and Forecast to 2031 (US$ Thousand)

7.4 3D Bioprinting

7.4.1 Overview
7.4.2 3D Bioprinting: Europe Human Liver Models Market – Revenue and Forecast to 2031 (US$ Thousand)

8. Europe Human Liver Models Market Analysis – by Application

8.1 Drug Discovery

8.1.1 Overview
8.1.2 Drug Discovery: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

8.2 Educational

8.2.1 Overview
8.2.2 Educational: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

9. Europe Human Liver Models Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview
9.1.2 Educational: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

9.2 Research Institutes

9.2.1 Overview
9.2.2 Educational: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10. Europe Human Liver Models Market – Europe Analysis

10.1 Europe

10.1.1 Europe Human Liver Models Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Human Liver Models Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.1.1.1 UK: Europe Human Liver Models Market Breakdown, by Type
10.1.1.1.2 UK: Europe Human Liver Models Market Breakdown, by Application
10.1.1.1.3 UK: Europe Human Liver Models Market Breakdown, by End User

10.1.1.2 Germany: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.1.2.1 Germany: Europe Human Liver Models Market Breakdown, by Type
10.1.1.2.2 Germany: Europe Human Liver Models Market Breakdown, by Application
10.1.1.2.3 Germany: Europe Human Liver Models Market Breakdown, by End User

10.1.1.3 France: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.1.3.1 France: Europe Human Liver Models Market Breakdown, by Type
10.1.1.3.2 France: Europe Human Liver Models Market Breakdown, by Application
10.1.1.3.3 France: Europe Human Liver Models Market Breakdown, by End User

10.1.1.4 Russia: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.1.4.1 Russia: Europe Human Liver Models Market Breakdown, by Type
10.1.1.4.2 Russia: Europe Human Liver Models Market Breakdown, by Application
10.1.1.4.3 Russia: Europe Human Liver Models Market Breakdown, by End User

10.1.1.5 Italy: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.1.5.1 Italy: Europe Human Liver Models Market Breakdown, by Type
10.1.1.5.2 Italy: Europe Human Liver Models Market Breakdown, by Application
10.1.1.5.3 Italy: Europe Human Liver Models Market Breakdown, by End User

10.1.1.6 Rest of Europe: Europe Human Liver Models Market – Revenue and Forecast to 2028 (US$ Thousand)

10.1.1.6.1 Rest of Europe: Europe Human Liver Models Market Breakdown, by Type
10.1.1.6.2 Rest of Europe: Europe Human Liver Models Market Breakdown, by Application
10.1.1.6.3 Rest of Europe: Europe Human Liver Models Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Human Liver Models Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 BioIVT

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 CELLINK

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 CN Bio Innovations

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Cyprio

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Emulate, Inc.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 InSphero

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Kerafast

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Kirkstall

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 MIMETAS BV

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 THERMO FISHER SCIENTIFIC INC.

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights